http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2112545-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ba7f369fbb6c3ebc792c495fe406f64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0a107c165e1ef3c66f73929e70ab8af
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-165
filingDate 1995-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6f70cad9bf5fc8bb9918266eb8cad84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c620e5b1d87c1106bbec3ed50a264e9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd1c2b8bc443d15a0eb156052c1bd9de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c4ea04b3ef360d8606357746b8dc14b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c985c56f315e28b2910bd81b071cf4be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6cfdff48414567a85b0207e4de1c441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64544b98f2abc1ba2267ff20fcdf8c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d13679cd194d2d406a9b8f15d98d273
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45532029a6742f74f64a519006aaa061
publicationDate 1998-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2112545-C1
titleOfInvention Method of live antimeasles vaccine preparing
abstract FIELD: medicine, vaccines. SUBSTANCE: suspension of validated diploid cells of culture L-68 at concentration 200 000-300 000 cells/ml is infected with vaccine strain of measles virus. Multiple of infection is 0.1-0.01 TCD 50/cell. Infected cells are cultured at 32-35 C. After monolayer formation inert proteins of cultured medium are removed by 6-fold washing out with nutrient medium. Virus-containing liquid is collected at least once in every 24 h. Viral pourings at titer 5-6 lg TCD 50/0.5 ml and at protein content 16 mcg/ml, not above, are combined. Cellular detritus is removed by filtration, stabilized with sorbitol-gelatin and subjected for lyophilic drying. EFFECT: improved method of vaccine preparing. 3 cl, 3 tbl
priorityDate 1995-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID93934
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID93934
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11234
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415791321
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664

Total number of triples: 43.